TRAT1 and neoplasm: The results revealed that a high-level expression of TRIM was associated with an advanced TNM stage (OR = 2.26, 95% CI: 1.25–4.10), deeper depth of tumor invasion (OR = 2.01, 95% CI: 1.04–3.88), poor tumor differentiation (OR = 0.63, 95% CI: 0.44–0.90), lymph node metastasis (OR = 2.99, 95% CI: 2.19–4.09) and perineural invasion (OR = 1.95, 95% CI: 1.18–3.23).